This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
HNP1, HD5, and RC101 inhibited SARS-CoV-2 entry, while HNP4 and HD6 showed weak activity.
Why it matters
Understanding how human defensins work against SARS-CoV-2 could lead to new therapeutic strategies for COVID-19. This research highlights the potential of innate immune factors in combating viral infections.
How the study worked
The study tested the antiviral effects of various human defensins on pseudotyped and replication-competent SARS-CoV-2 viruses.
What this study cannot tell us
The study primarily focused on in vitro models, which may not fully replicate human responses to infection.
Read the original research
Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
Viruses, 13(7)
Citation
Xu, Chuan; Wang, Annie; Marin, Mariana; Honnen, William; Ramasamy, Santhamani; Porter, Edith; Subbian, Selvakumar; Pinter, Abraham; Melikyan, Gregory B; Lu, Wuyuan; Chang, Theresa L. (2021). Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.. Viruses, 13(7). https://doi.org/10.3390/v13071246